Drug intelligence / Profile preview

coenzyme Q10 + trimetazidine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Coenzyme Q10 + trimetazidine is a fixed-dose combination of two agents with complementary mechanisms used primarily for cardiovascular protection. - **Coenzyme Q10 (ubiquinone)** is a naturally occurring antioxidant involved in mitochondrial electron transport and cellular energy production. It reduces oxidative stress and supports myocardial function by improving ATP synthesis. - **Trimetazidine** is a metabolic modulator that shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation, thereby enhancing myocardial efficiency under ischemic conditions. It also exhibits antioxidant and anti-inflammatory properties. The combination has demonstrated superior efficacy over monotherapy in reducing markers of inflammation and oxidative stress, improving left ventricular systolic function, and lowering biochemical markers of myocardial damage in acute viral myocarditis[1][2][5]. It has also shown protective effects against drug-induced cardiotoxicity (e.g., cisplatin) by attenuating oxidative stress[3][6]. The primary indications studied include acute viral myocarditis, chronic heart failure, and prevention of cardiotoxicity.

Other names
coenzyme Q10 and trimetazidineCoQ10 + trimetazidineCQ10 + trimetazidineTMZ + CoQ10
02

Targets

NADH:ubiquinone oxidoreductase subunit familyACAA2 (Acetyl-CoA acyltransferase 2)

Beyond the preview

Go deeper on coenzyme Q10 + trimetazidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on coenzyme Q10 + trimetazidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call